The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Molecular Diagnostics and NAT-Global Market Insights and Sales Trends 2025
Synopsis
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
The global Molecular Diagnostics and NAT market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostics and NAT in various end use industries. The expanding demands from the Hospitals and Clinics, Research Institutes and Diagnostic Centers,, are propelling Molecular Diagnostics and NAT market. Amplification Technologies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Amplified Gene Detection Technologies segment is estimated at % CAGR for the next seven-year period.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostics and NAT, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostics and NAT market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostics and NAT market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostics and NAT sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostics and NAT covered in this report include Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark and Siemens Healthcare, etc.
The global Molecular Diagnostics and NAT market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Global Molecular Diagnostics and NAT market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostics and NAT market, Segment by Type:
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Global Molecular Diagnostics and NAT market, by Application
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Diagnostics and NAT companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
The global Molecular Diagnostics and NAT market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostics and NAT in various end use industries. The expanding demands from the Hospitals and Clinics, Research Institutes and Diagnostic Centers,, are propelling Molecular Diagnostics and NAT market. Amplification Technologies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Amplified Gene Detection Technologies segment is estimated at % CAGR for the next seven-year period.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostics and NAT, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostics and NAT market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostics and NAT market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostics and NAT sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostics and NAT covered in this report include Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark and Siemens Healthcare, etc.
The global Molecular Diagnostics and NAT market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Global Molecular Diagnostics and NAT market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostics and NAT market, Segment by Type:
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Global Molecular Diagnostics and NAT market, by Application
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Diagnostics and NAT companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Molecular Diagnostics and NAT
1.1 Molecular Diagnostics and NAT Market Overview
1.1.1 Molecular Diagnostics and NAT Product Scope
1.1.2 Molecular Diagnostics and NAT Market Status and Outlook
1.2 Global Molecular Diagnostics and NAT Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Molecular Diagnostics and NAT Market Size by Region (2018-2029)
1.4 Global Molecular Diagnostics and NAT Historic Market Size by Region (2018-2023)
1.5 Global Molecular Diagnostics and NAT Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Molecular Diagnostics and NAT Market Size (2018-2029)
1.6.1 North America Molecular Diagnostics and NAT Market Size (2018-2029)
1.6.2 Europe Molecular Diagnostics and NAT Market Size (2018-2029)
1.6.3 Asia-Pacific Molecular Diagnostics and NAT Market Size (2018-2029)
1.6.4 Latin America Molecular Diagnostics and NAT Market Size (2018-2029)
1.6.5 Middle East & Africa Molecular Diagnostics and NAT Market Size (2018-2029)
2 Molecular Diagnostics and NAT Market by Type
2.1 Introduction
2.1.1 Amplification Technologies
2.1.2 Amplified Gene Detection Technologies
2.1.3 DNA And Oligonucleotide Microarrays
2.1.4 Gene Sequencing
2.2 Global Molecular Diagnostics and NAT Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Molecular Diagnostics and NAT Historic Market Size by Type (2018-2023)
2.2.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Molecular Diagnostics and NAT Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Molecular Diagnostics and NAT Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Molecular Diagnostics and NAT Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Molecular Diagnostics and NAT Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Molecular Diagnostics and NAT Revenue Breakdown by Type (2018-2029)
3 Molecular Diagnostics and NAT Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Research Institutes
3.1.3 Diagnostic Centers
3.2 Global Molecular Diagnostics and NAT Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Molecular Diagnostics and NAT Historic Market Size by Application (2018-2023)
3.2.2 Global Molecular Diagnostics and NAT Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Molecular Diagnostics and NAT Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Molecular Diagnostics and NAT Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Molecular Diagnostics and NAT Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Molecular Diagnostics and NAT Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Molecular Diagnostics and NAT Revenue Breakdown by Application (2018-2029)
4 Molecular Diagnostics and NAT Competition Analysis by Players
4.1 Global Molecular Diagnostics and NAT Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostics and NAT as of 2022)
4.3 Date of Key Players Enter into Molecular Diagnostics and NAT Market
4.4 Global Top Players Molecular Diagnostics and NAT Headquarters and Area Served
4.5 Key Players Molecular Diagnostics and NAT Product Solution and Service
4.6 Competitive Status
4.6.1 Molecular Diagnostics and NAT Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Molecular Diagnostics and NAT Products, Services and Solutions
5.1.4 Roche Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Molecular Diagnostics and NAT Products, Services and Solutions
5.2.4 Abbott Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 BD
5.3.1 BD Profile
5.3.2 BD Main Business
5.3.3 BD Molecular Diagnostics and NAT Products, Services and Solutions
5.3.4 BD Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.3.5 Biomerieux Recent Developments
5.4 Biomerieux
5.4.1 Biomerieux Profile
5.4.2 Biomerieux Main Business
5.4.3 Biomerieux Molecular Diagnostics and NAT Products, Services and Solutions
5.4.4 Biomerieux Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.4.5 Biomerieux Recent Developments
5.5 Qiagen
5.5.1 Qiagen Profile
5.5.2 Qiagen Main Business
5.5.3 Qiagen Molecular Diagnostics and NAT Products, Services and Solutions
5.5.4 Qiagen Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.5.5 Qiagen Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Agilent
5.7.1 Agilent Profile
5.7.2 Agilent Main Business
5.7.3 Agilent Molecular Diagnostics and NAT Products, Services and Solutions
5.7.4 Agilent Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.7.5 Agilent Recent Developments
5.8 GenMark
5.8.1 GenMark Profile
5.8.2 GenMark Main Business
5.8.3 GenMark Molecular Diagnostics and NAT Products, Services and Solutions
5.8.4 GenMark Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.8.5 GenMark Recent Developments
5.9 Siemens Healthcare
5.9.1 Siemens Healthcare Profile
5.9.2 Siemens Healthcare Main Business
5.9.3 Siemens Healthcare Molecular Diagnostics and NAT Products, Services and Solutions
5.9.4 Siemens Healthcare Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Healthcare Recent Developments
5.10 AutoGenomics
5.10.1 AutoGenomics Profile
5.10.2 AutoGenomics Main Business
5.10.3 AutoGenomics Molecular Diagnostics and NAT Products, Services and Solutions
5.10.4 AutoGenomics Molecular Diagnostics and NAT Revenue (US$ Million) & (2018-2023)
5.10.5 AutoGenomics Recent Developments
6 North America
6.1 North America Molecular Diagnostics and NAT Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Molecular Diagnostics and NAT Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics and NAT Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Molecular Diagnostics and NAT Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics and NAT Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Molecular Diagnostics and NAT Market Dynamics
11.1 Molecular Diagnostics and NAT Industry Trends
11.2 Molecular Diagnostics and NAT Market Drivers
11.3 Molecular Diagnostics and NAT Market Challenges
11.4 Molecular Diagnostics and NAT Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
